Results 21 to 30 of about 12,798 (141)
Acute anterior segment biometric effects of brimonidine assessed by swept source OCT supporting its use in managing visual disturbances [PDF]
Scientific ReportsThis study quantified the effects of topical brimonidine 0.2% on anterior segment anatomy using swept-source optical coherence tomography (SS-OCT) in a prospective, interventional design. Seventy eyes were evaluated with the Anterion system.
Pablo Alexis Limón-Zurita +2 more
doaj +2 more sources
Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension [PDF]
Clinical Ophthalmology, 2008 Anna Galanopoulos1, Ivan Goldberg21Senior Visiting Ophthalmologist, South Australian Institute of Ophthalmology and Dept of Ophthalmology and Visual Sciences, University of Adelaide, South Australia; 2Clinical Associate Professor, University of Sydney ...
Anna Galanopoulos, Ivan Goldberg
doaj +2 more sources
Effect of brimonidine tartrate 0.15% on scotopic pupil size and upper eyelid position: controlled trial. [PDF]
Eye (Lond), 2021 Background To evaluate the effect of brimonidine tartrate 0.15% ophthalmic solution on pupil size under scotopic condition and upper eyelid position. Methods This study comprised 72 eyes of 36 healthy subjects. A single drop of brimonidine tartrate 0.15%
Tuncer I +6 more
europepmc +2 more sources
Nummular keratitis: A rare manifestation of brimonidine allergy
Oman Journal of OphthalmologyA 32-year-old male, with juvenile open-angle glaucoma on chronic antiglaucoma therapy and recently introduced brimonidine eye drops to the treatment regimen, developed bilateral follicular conjunctivitis with subepithelial infiltrates (SEIs) initially ...
Maitha Al Asmi, Aisha Al Busaidi
doaj +2 more sources
Clinical Ophthalmology, 2008 Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj +1 more source
Clinical Ophthalmology, 2015 The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum] Tsumura T, Yoshikawa K, Kimura T, et al. Clin Ophthalmol. 2014;8:1681–1687.
Tsumura T +7 more
doaj +1 more source
Ophthalmology and Therapy, 2020 Introduction This study was aimed to compare ocular tissue distribution and systemic exposure of brimonidine and timolol after single topical administration to rabbits of fixed-combination ophthalmic solution of 0.1% brimonidine tartrate and 0.5% timolol
Gen Suzuki +5 more
doaj +1 more source
Ophthalmology and Therapy, 2023 Introduction The factors related to the ocular penetration of drugs after the administration of eye drops in humans have not been examined in detail. Therefore, this study assessed the influence of patient factors on the intraocular penetration of eye ...
Eriko Kunikane +3 more
doaj +1 more source
, 2023 AimsTo investigate the differences between 0.2 and 0.15% brimonidine tartrate eye drops for anti-mydriatic effects and the optical quality under different light conditions.MethodsThis prospective study involved 80 consecutive high myopia patients ...
Xiaodi Zhang (2698000) +6 more
core +1 more source
, 2023 AimsTo investigate the differences between 0.2 and 0.15% brimonidine tartrate eye drops for anti-mydriatic effects and the optical quality under different light conditions.MethodsThis prospective study involved 80 consecutive high myopia patients ...
Wentao Liu +13 more
core +1 more source